Targeting insulin-like growth factor 1 receptor restricts development and severity of secondary lymphedema in mice.

Saved in:
Bibliographic Details
Title: Targeting insulin-like growth factor 1 receptor restricts development and severity of secondary lymphedema in mice.
Authors: Yuan Y; O'Brien Institute Department, St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Levy SM; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Nuclear Medicine, Royal Melbourne Hospital, Parkville, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Yeo YQ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Shayan R; O'Brien Institute Department, St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.; Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia.; Department of Plastic Surgery, St. Vincent's Hospital, Darlinghurst, VIC, Australia.; Department of Plastic Surgery, Alfred Health, Melbourne, VIC, Australia., Karnezis T; O'Brien Institute Department, St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia., Stacker SA; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia., Achen MG; O'Brien Institute Department, St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia.
Source: IScience [iScience] 2025 Feb 03; Vol. 28 (3), pp. 111948. Date of Electronic Publication: 2025 Feb 03 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2025.111948